206 related articles for article (PubMed ID: 32014051)
21. Genetic investigation of multicentric glioblastoma multiforme: case report.
Schroeder B; Shah N; Rostad S; McCullough B; Aguedan B; Foltz G; Cobbs C
J Neurosurg; 2016 May; 124(5):1353-8. PubMed ID: 26473785
[TBL] [Abstract][Full Text] [Related]
22. Comparison of microRNA expression levels between initial and recurrent glioblastoma specimens.
Ilhan-Mutlu A; Wöhrer A; Berghoff AS; Widhalm G; Marosi C; Wagner L; Preusser M
J Neurooncol; 2013 May; 112(3):347-54. PubMed ID: 23420397
[TBL] [Abstract][Full Text] [Related]
23. The role of TP53 gain-of-function mutation in multifocal glioblastoma.
Olafson LR; Gunawardena M; Nixdorf S; McDonald KL; Rapkins RW
J Neurooncol; 2020 Mar; 147(1):37-47. PubMed ID: 32002804
[TBL] [Abstract][Full Text] [Related]
24. Cerebellar glioblastoma: a clinical series with contemporary molecular analysis.
Hong B; Banan R; Christians A; Nakamura M; Lalk M; Lehmann U; Hartmann C; Krauss JK
Acta Neurochir (Wien); 2018 Nov; 160(11):2237-2248. PubMed ID: 30203362
[TBL] [Abstract][Full Text] [Related]
25. Multifocal epithelioid glioblastoma mimicking cerebral metastasis: case report.
Gasco J; Franklin B; Fuller GN; Salinas P; Prabhu S
Neurocirugia (Astur); 2009 Dec; 20(6):550-4. PubMed ID: 19967320
[TBL] [Abstract][Full Text] [Related]
26. Intratumoral Genetic and Functional Heterogeneity in Pediatric Glioblastoma.
Hoffman M; Gillmor AH; Kunz DJ; Johnston MJ; Nikolic A; Narta K; Zarrei M; King J; Ellestad K; Dang NH; Cavalli FMG; Kushida MM; Coutinho FJ; Zhu Y; Luu B; Ma Y; Mungall AJ; Moore R; Marra MA; Taylor MD; Pugh TJ; Dirks PB; Strother D; Lafay-Cousin L; Resnick AC; Scherer S; Senger DL; Simons BD; Chan JA; Morrissy AS; Gallo M
Cancer Res; 2019 May; 79(9):2111-2123. PubMed ID: 30877103
[TBL] [Abstract][Full Text] [Related]
27. Reactivation of human neurotropic JC virus expressing oncogenic protein in a recurrent glioblastoma multiforme.
Del Valle L; Azizi SA; Krynska B; Enam S; Croul SE; Khalili K
Ann Neurol; 2000 Dec; 48(6):932-6. PubMed ID: 11117551
[TBL] [Abstract][Full Text] [Related]
28. Molecular and clonal evolution in recurrent metastatic gliosarcoma.
Anderson KJ; Tan AC; Parkinson J; Back M; Kastelan M; Newey A; Brewer J; Wheeler H; Hudson AL; Amin SB; Johnson KC; Barthel FP; Verhaak RGW; Khasraw M
Cold Spring Harb Mol Case Stud; 2020 Feb; 6(1):. PubMed ID: 31896544
[TBL] [Abstract][Full Text] [Related]
29. Distinctive Spatiotemporal Stability of Somatic Mutations in Metastasized Microsatellite-stable Colorectal Cancer.
Jesinghaus M; Wolf T; Pfarr N; Muckenhuber A; Ahadova A; Warth A; Goeppert B; Sers C; Kloor M; Endris V; Stenzinger A; Weichert W
Am J Surg Pathol; 2015 Aug; 39(8):1140-7. PubMed ID: 25786087
[TBL] [Abstract][Full Text] [Related]
30. Glioblastoma multiforme with extraneural metastases in the absence of previous surgery.
Hulbanni S; Goodman PA
Cancer; 1976 Mar; 37(3):1577-83. PubMed ID: 177171
[TBL] [Abstract][Full Text] [Related]
31. Spatial analysis of recurrent glioblastoma reveals perivascular niche organization.
Onubogu U; Gatenbee CD; Prabhakaran S; Wolfe KL; Oakes B; Salatino R; Vaubel R; Szentirmai O; Anderson AR; Janiszewska M
JCI Insight; 2024 May; 9(12):. PubMed ID: 38805346
[TBL] [Abstract][Full Text] [Related]
32. Clonal evolution of glioblastoma under therapy.
Wang J; Cazzato E; Ladewig E; Frattini V; Rosenbloom DI; Zairis S; Abate F; Liu Z; Elliott O; Shin YJ; Lee JK; Lee IH; Park WY; Eoli M; Blumberg AJ; Lasorella A; Nam DH; Finocchiaro G; Iavarone A; Rabadan R
Nat Genet; 2016 Jul; 48(7):768-76. PubMed ID: 27270107
[TBL] [Abstract][Full Text] [Related]
33. Overcoming therapeutic resistance in glioblastoma: the way forward.
Osuka S; Van Meir EG
J Clin Invest; 2017 Feb; 127(2):415-426. PubMed ID: 28145904
[TBL] [Abstract][Full Text] [Related]
34. Concurrent TERT promoter and BRAF V600E mutation in epithelioid glioblastoma and concomitant low-grade astrocytoma.
Matsumura N; Nakajima N; Yamazaki T; Nagano T; Kagoshima K; Nobusawa S; Ikota H; Yokoo H
Neuropathology; 2017 Feb; 37(1):58-63. PubMed ID: 27302309
[TBL] [Abstract][Full Text] [Related]
35. Human TERT promoter mutation enables survival advantage from MGMT promoter methylation in IDH1 wild-type primary glioblastoma treated by standard chemoradiotherapy.
Nguyen HN; Lie A; Li T; Chowdhury R; Liu F; Ozer B; Wei B; Green RM; Ellingson BM; Wang HJ; Elashoff R; Liau LM; Yong WH; Nghiemphu PL; Cloughesy T; Lai A
Neuro Oncol; 2017 Mar; 19(3):394-404. PubMed ID: 27571882
[TBL] [Abstract][Full Text] [Related]
36. Glioblastoma Recurrence and the Role of O
Storey K; Leder K; Hawkins-Daarud A; Swanson K; Ahmed AU; Rockne RC; Foo J
JCO Clin Cancer Inform; 2019 Feb; 3():1-12. PubMed ID: 30758983
[TBL] [Abstract][Full Text] [Related]
37. Structure and evolution of double minutes in diagnosis and relapse brain tumors.
Xu K; Ding L; Chang TC; Shao Y; Chiang J; Mulder H; Wang S; Shaw TI; Wen J; Hover L; McLeod C; Wang YD; Easton J; Rusch M; Dalton J; Downing JR; Ellison DW; Zhang J; Baker SJ; Wu G
Acta Neuropathol; 2019 Jan; 137(1):123-137. PubMed ID: 30267146
[TBL] [Abstract][Full Text] [Related]
38. A case of osteoclast-like giant cell-rich epithelioid glioblastoma with BRAF V600E mutation.
Funata N; Nobusawa S; Yamada R; Shinoura N
Brain Tumor Pathol; 2016 Jan; 33(1):57-62. PubMed ID: 26602910
[TBL] [Abstract][Full Text] [Related]
39. High prevalence of TP53 mutations is associated with poor survival and an EMT signature in gliosarcoma patients.
Cho SY; Park C; Na D; Han JY; Lee J; Park OK; Zhang C; Sung CO; Moon HE; Kim Y; Kim JH; Kim JJ; Khang SK; Nam DH; Choi JW; Suh YL; Kim DG; Park SH; Youn H; Yun K; Kim JI; Lee C; Paek SH; Park H
Exp Mol Med; 2017 Apr; 49(4):e317. PubMed ID: 28408749
[TBL] [Abstract][Full Text] [Related]
40. Clinicopathological and genetic association between epithelioid glioblastoma and pleomorphic xanthoastrocytoma.
Furuta T; Miyoshi H; Komaki S; Arakawa F; Morioka M; Ohshima K; Nakada M; Sugita Y
Neuropathology; 2018 Jun; 38(3):218-227. PubMed ID: 29532523
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
